NEXTERONE

Peak

amiodarone hydrochloride

NDAINJECTIONINJECTABLE
Approved
Dec 2008
Lifecycle
Peak
Competitive Pressure
8/100

Mechanism of Action

drug, but it possesses electrophysiologic characteristics of all four Vaughan Williams classes. Like class I drugs, amiodarone blocks sodium channels at rapid pacing frequencies, and like class II drugs, amiodarone exerts a noncompetitive antisympathetic action. One of its main effects, with…

Loss of Exclusivity

LOE Date
Mar 13, 2029
36 months away
Patent Expiry
Mar 13, 2029

Patent Records (1)

Patent #ExpiryTypeUse Code
7635773
Mar 13, 2029
Product